2016 BIOPACIFIC CONFERENCE by CABS (Early Bird Registration by 04/15/16)
anonymous-100082 04/14 38874.0/1
2016 BIOPACIFIC CONFERENCE by CABS (Early Bird Registration by 04/15/16)
Date: May 7, 2016 @ 8:00 am – @ 9:00 pm
Location: San Mateo Marriott, 1770 South Amphlett Blvd, San Mateo, CA 94402
Early Bird Registration by 04/15/16 (click the link below)
http://www.cabsweb.org/events/2143408/Registration+is+Open%3A+2016+BioPacific+Conference/
18th Annual Conference of the Chinese American BioPharmaceutical Society & Inaugural BioPacific Partnering
Our meeting will showcase:
· Winner of 2016 CABS K. Fong Award in Life Sciences: Dr. Gerald Chan, co-founder of Morningside
· Success stories of entrepreneurs and emerging companies including Adheron Therapeutics and PaxVax
· Most promising areas in life sciences including cancer immunotherapy and CRISPR/dCas9 technology
· BioPharmaceutical Development - China & Global Considerations
· US-China Cross-Border Healthcare Investment & Entrepreneurship
· Two-day BioPacific Forum to facilitate interactions including project introduction and talent recruitment between attendees and sponsors
Confirmed speakers and panelists:
• Dr. Gerald Chan, Co-founder, Morningside
• Hari Kumar, CEO, Adheron Therapeutics
• Piers Whitehead, EVP & CBO, PaxVax
• Mark Selby, Ph.D., Senior Director of Immuno-Oncology, Bristol-Myers Squibb
• Lei Stanley Qi, Ph.D., Assistant Professor, Stanford University School of Medicine
• Darren Ji, Ph.D.,MBA, Vice President and Global Head, Roche Partnering Asia and Emerging Markets
• Tom Irving, J.D., Partner & Wen Li, Ph.D., Associate, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
• Robert Lou, Manager Director, Ningbo Kangtaibo Technology Development Co. Ltd
• Hui Zhang, Deputy Director, Ningbo Hangzhou Bay New Zone Investment and Partnership Branch
• Jinqun Yin, MBA, Vice President, Chengdu Kanghong Pharmaceutical Group Co., Ltd
• Charles C. Comey, J.D., Partner, Morrison & Foerster
• Shawn Qian, Ph.D., CEO, Neupharma
• Xiaodong Yang, M.D., Ph.D., President and CEO, Apexigen
• Xian-Ping Lu, Ph.D., Co-Founder, CEO and CSO, Chipscreen Biosciences
• Dan Zhang, M.D., Ph.D., CEO, Fountain Medical Development
• Connie Sun, Ph.D, Senior Vice President, Business and Corporate Development, Pharmaron
• Cheni Kwok, Ph.D, CLP Senior Consultant, Medicilon, Managing Partner, Linear Dreams
• Alexis Ji, Ph.D., MBA, Principal, WuXi Healthcare Ventures
• James Zhao, M.D., M.S., MBA, Founding Partner, LYFE Capital
• Yuwen Liu, MBA, MS, Founding Partner, BoHe Angel Fund
• Min Cui, Ph.D., Founding Partner and Managing Director, Decheng Capital
• Vincent Liu, Ph.D., MBA, Senior Consultant, Wanbang Biopharmaceutical Shanghai Fosun Pharmaceutical (Group) Co., Ltd
• Shawn Lee, Ph.D. Vice- Chairman, Xinbang Pharmaceutical, President & CEO, CPC Scientific Inc.
• Cheng Liu, Ph.D., Founder and CEO, Eureka Therapeutics
• Jennifer Hu, Ph.D., Venture Partner, Qiming Venture Partners
See conference agenda at:
http://biopacificconference.org/
